[Basis of immunosuppressive effect of D-penecillamine].
D000917:Antibody Formation / Q000187:drug effects*; D001327:Autoimmune Diseases / Q000188:drug therapy; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use; D008213:Lymphocyte Activation / Q000187:drug effects; D010396:Penicillamine / Q000494:pharmacology* / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000187:drug effects
D007166:Immunosuppressive Agents; D010396:Penicillamine
Grundlagen der immunsuppressiven Wirkung von D-Penicillamin